Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.
Tag: Pancreatic Cancer Awareness Month
Respected Pancreatic and Hepatobiliary Surgeon Offering Cutting Edge Cancer Treatment
With expertise in robotic pancreatic surgery and laparoscopic liver (hepatobiliary) surgery, Dr. Debashish Bose is committed to remaining on the forefront of patient care advances and providing new treatment methods for patients facing a cancer diagnosis. Dr. Bose is one…
Pancreatic Cysts, Cancer and Awareness: Answers from an Expert
Russell Langan, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center (SBMC) and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more information on monitoring pancreatic cysts and pancreatic cancer.
Advances in Pancreatic Cancer Research and Treatment
Pancreatic cancer is difficult to detect and treat, so researchers are continually advancing working on understanding of the disease through research. Rutgers Cancer Institute of New Jersey expert shares an overview of research and treatment advances for pancreatic cancer.
New Research in JNCCN Evaluates Cost-Effectiveness of Olaparib, a PARP Inhibitor, for Metastatic Pancreatic Cancer
New research in the November 2020 issue of JNCCN identifies metastatic pancreatic cancer patient subgroups with the highest relative cost-effectiveness from maintenance olaparib, a PARP inhibitor.
Learning more about Pancreatic Cancer
With the recent passing of Jeopardy host Alex Trebek, Rutgers Cancer Institute of New Jersey expert explains pancreatic cancer and the progress being made with this disease through research and clinical trials.